Mervyn Middleton

Biopharma Group, Senior Scientist

After earning a BSc (Hons) in Biochemistry from the University of Portsmouth in 2009, Mervyn joined Biopharma Group where he worked through to 2015, gaining expertise in product analysis and freeze drying cycle development. Returning in 2021 as a Senior Scientist, Mervyn has worked on over 50 projects, including prelyophilised and lyophilised product characterisation, formulation development, freeze drying cycle optimisation, process auditing, and consultancy across all stages of lyo development and scale-up. 

Dieter Palmberger

Co-Founder & Chief Technology Officer of bespark*bio

bespark*bio, a visionary biotech startup, is revolutionizing process development for next-generation biotherapeutics. Specializing in viral vectors, bionanoparticles, and biologics, bespark*bio empowers its clients to bring transformative therapies to market faster and more cost-effectively. Dr. Dieter Palmberger, leads the company’s scientific and technical strategy. With a PhD in virus-based protein expression and extensive experience in bioprocess development for live viral vectors and biologics, Dr. Palmberger has held key roles in Austria’s biotech landscape.